Abstract：
BACKGROUND: The implementation of the NVBP policy has generated considerable reductions in drug procurement prices and an increase in the market share of the NVBP drugs.This study aimed to investigate patients\' attitudes towards switching to drugs of national volume-based procurement (NVBP) and identify their underlying influencing factors in Wuhan, China.
METHODS: A total of 21 eligible patients from the Wuhan Union Hospital who were switched to NVBP drugs between January 2022 and May 2022 were included in our study. Semi-structured face-to-face interviews were conducted to collect interview information and the interview data was analyzed by the Colaizzi seven-step method.
RESULTS: Twenty-one semi-structured face-to-face interviews were conducted. The duration of each interview was 25-35 min and three themes related to patients\' attitudes and their influencing factors were extracted, including (1) Patients\' perception of the NVBP drugs; (2) Family and social influence to patients; (3) Medication habits of patients. This study found: 1) 71.4% patients (15/21) showed a positive attitude towards switching to NVBP medicines; 2)80.9% patients (17/21) have felt a significant reduction in their medication cost after the implementation of the NVBP policy; 3)Advices from healthcare professionals and health insurance reimbursement policies showed great impacts on patients\' attitude towards switching to NVBP drugs; 4)Attitudes towards switching to NVBP drugs varied considerably among patients with different severities of disease.
CONCLUSIONS: The implementation of the NVBP policy has significantly reduced the cost of healthcare for patients and has been supported by71.4% (15 of 21) patients. However, some issues have been identified in the implementation of the policy in this study. Health professionals in general need to contribute more efforts to improve patients\' preconceptions about the NVBP drugs and boost their confidence in the NVBP drugs.
METHODS: A total of 21 eligible patients from the Wuhan Union Hospital who were switched to NVBP drugs between January 2022 and May 2022 were included in our study. Semi-structured face-to-face interviews were conducted to collect interview information and the interview data was analyzed by the Colaizzi seven-step method.
RESULTS: Twenty-one semi-structured face-to-face interviews were conducted. The duration of each interview was 25-35 min and three themes related to patients\' attitudes and their influencing factors were extracted, including (1) Patients\' perception of the NVBP drugs; (2) Family and social influence to patients; (3) Medication habits of patients. This study found: 1) 71.4% patients (15/21) showed a positive attitude towards switching to NVBP medicines; 2)80.9% patients (17/21) have felt a significant reduction in their medication cost after the implementation of the NVBP policy; 3)Advices from healthcare professionals and health insurance reimbursement policies showed great impacts on patients\' attitude towards switching to NVBP drugs; 4)Attitudes towards switching to NVBP drugs varied considerably among patients with different severities of disease.
CONCLUSIONS: The implementation of the NVBP policy has significantly reduced the cost of healthcare for patients and has been supported by71.4% (15 of 21) patients. However, some issues have been identified in the implementation of the policy in this study. Health professionals in general need to contribute more efforts to improve patients\' preconceptions about the NVBP drugs and boost their confidence in the NVBP drugs.
摘要：
背景：NVBP政策的实施大大降低了药品采购价格，并增加了NVBP药品的市场份额。本研究旨在调查武汉市患者对转向国家批量采购（NVBP）药物的态度，并确定其潜在影响因素。中国。
方法：本研究纳入了武汉协和医院在2022年1月至2022年5月期间转用NVBP药物的21例符合条件的患者。进行半结构化面对面访谈，收集访谈信息，并采用Colaizzi七步法对访谈数据进行分析。
结果：进行了21次半结构化面对面访谈。每次访谈的持续时间为25-35分钟，并提取与患者态度及其影响因素相关的三个主题，包括（1）患者对NVBP药物的认知；（2）家庭和社会对患者的影响；（3）患者的用药习惯。这项研究发现：1）71.4％的患者（15/21）对改用NVBP药物持积极态度；2）80.9％的患者（17/21）在实施NVBP政策后感到其药物成本显着降低；3）医疗保健专业人员和健康保险报销政策的建议对患者改用NVBP药物的态度有很大影响；4）在不同严重程度的患者中，改用NVBP药物的态度差异很大。
结论：NVBP政策的实施显著降低了患者的医疗费用，并得到了71.4%（21个中的15个）患者的支持。然而,在这项研究中，政策的实施中发现了一些问题。卫生专业人员一般需要做出更多的努力，以改善患者对NVBP药物的成见，并增强他们对NVBP药物的信心。
方法：本研究纳入了武汉协和医院在2022年1月至2022年5月期间转用NVBP药物的21例符合条件的患者。进行半结构化面对面访谈，收集访谈信息，并采用Colaizzi七步法对访谈数据进行分析。
结果：进行了21次半结构化面对面访谈。每次访谈的持续时间为25-35分钟，并提取与患者态度及其影响因素相关的三个主题，包括（1）患者对NVBP药物的认知；（2）家庭和社会对患者的影响；（3）患者的用药习惯。这项研究发现：1）71.4％的患者（15/21）对改用NVBP药物持积极态度；2）80.9％的患者（17/21）在实施NVBP政策后感到其药物成本显着降低；3）医疗保健专业人员和健康保险报销政策的建议对患者改用NVBP药物的态度有很大影响；4）在不同严重程度的患者中，改用NVBP药物的态度差异很大。
结论：NVBP政策的实施显著降低了患者的医疗费用，并得到了71.4%（21个中的15个）患者的支持。然而,在这项研究中，政策的实施中发现了一些问题。卫生专业人员一般需要做出更多的努力，以改善患者对NVBP药物的成见，并增强他们对NVBP药物的信心。
